Skip to main content

US ClosedU.S. Closed

ARDX: Ardelyx, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines.

52W Range

2ndpctl

Volume

1.25×avg

Market Cap

941.18MUSD

P/E Ratio

-16.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Ardelyx, Inc.

ARDXNASDAQ Global Market·USD·Closed

Ardelyx, Inc.

ARDXNASDAQ·USD·Closed

$3.81

−0.26%

$3.81

−$0.01 (0.26%)

52W Range

2ndpctl

Volume

1.25×avg

Mkt Cap

941.18MUSD

P/E

-16.9TTM

Div Yield

–ann